Loading...
XNAS
XWEL
Market cap82mUSD
Jul 15, Last price  
1.01USD
1D
1.54%
1Q
31.63%
IPO
-99.88%
Name

XWELL Inc

Chart & Performance

D1W1MN
P/E
P/S
2.79
EPS
Div Yield, %
Shrs. gr., 5y
180.08%
Rev. gr., 5y
-9.68%
Revenues
30m
-46.18%
020,000211,000718,000369,0001,100,0001,425,00022,687,00018,974,00048,823,00050,094,00048,515,0008,385,00073,729,00055,939,00030,109,000
Net income
-28m
L-14.98%
-7,332,000-6,149,000-9,942,000-7,479,000-20,841,000-52,433,000-109,677,000-11,157,000-24,006,000-28,840,000-37,205,000-20,530,000-92,232,0003,349,000-32,629,000-27,741,000
CFO
-16m
L-33.55%
-7,296,000-4,850,000-6,361,000-5,380,000-14,468,000-23,465,000-28,382,000-2,571,000-8,441,000-12,172,000-6,566,000-113,000-25,012,00015,642,000-24,188,000-16,074,000
Earnings
Aug 12, 2025

Profile

XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.
IPO date
Jun 18, 2010
Employees
363
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
30,109
-46.18%
55,939
-24.13%
Cost of revenue
47,339
75,060
Unusual Expense (Income)
NOPBT
(17,230)
(19,121)
NOPBT Margin
Operating Taxes
35
55
Tax Rate
NOPAT
(17,265)
(19,176)
Net income
(27,741)
-14.98%
(32,629)
-1,074.29%
Dividends
Dividend yield
Proceeds from repurchase of equity
(22)
(23,759)
BB yield
Debt
Debt current
4,804
2,586
Long-term debt
19,786
25,628
Deferred revenue
Other long-term liabilities
Net debt
1,490
(14,081)
Cash flow
Cash from operating activities
(16,074)
(24,188)
CAPEX
(1,905)
(6,837)
Cash from investing activities
5,650
(34,843)
Cash from financing activities
8
(27,377)
FCF
(12,433)
(20,122)
Balance
Cash
23,050
42,191
Long term investments
50
104
Excess cash
21,595
39,498
Stockholders' equity
(449,766)
(419,791)
Invested Capital
484,233
481,274
ROIC
ROCE
EV
Common stock shares outstanding
4,175
4,683
Price
Market cap
EV
EBITDA
(13,684)
(11,848)
EV/EBITDA
Interest
321
16,127
Interest/NOPBT